- Corporate Officers - B
- Breitmeyer James B
Insider Trading History of Breitmeyer James B
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Breitmeyer James B since 2009.
This trader's CIK number is 1244823.
At the time of last reporting, Breitmeyer James B was the Chief Executive Officer of Oncternal Therapeutics, Inc.. (stock ticker symbol ONCT).
Also see all insider trading activities at Oncternal Therapeutics, Inc..
Note that in the past
BREITMEYER JAMES B also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Oncternal Therapeutics, Inc. (ONCT) by Breitmeyer James B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | ONCT | 150,000 | $43,749 | 0 | $0 | 0 | $0 |
| 2022 | ONCT | 25,000 | $42,075 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cadence Pharmaceuticals Inc (CADX) by Breitmeyer James B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | CADX | 0 | $0 | 80,500 | $610,348 | 80,500 | $217,600 |
| 2010 | CADX | 0 | $0 | 42,000 | $374,863 | 42,000 | $134,399 |
| 2009 | CADX | 0 | $0 | 5,000 | $53,880 | 5,000 | $16,000 |
Yearly summary of insider trading at Zogenix, Inc. (ZGNX) by Breitmeyer James B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ZGNX | 0 | $0 | 10,000 | $500,000 | 10,000 | $89,900 |
Insider trading activities at 3 companies by Breitmeyer James B:
1. Oncternal Therapeutics, Inc. (ONCT)
2. Cadence Pharmaceuticals Inc (CADX)
3. Zogenix, Inc. (ZGNX)
Table 1. Insider trading of Oncternal Therapeutics, Inc. (ONCT) by Breitmeyer James B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-04-14 | ONCT | Buy | 50,000 | .29 | 14,750 |
| 2023-04-13 | ONCT | Buy | 100,000 | .29 | 28,999 |
| 2022-01-27 | ONCT | Buy | 25,000 | 1.68 | 42,075 |
Table 2. Insider trading of Cadence Pharmaceuticals Inc (CADX) by Breitmeyer James B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-11-03 | CADX | Sale | 12,500 | 5.70 | 71,300 |
| 2011-11-02 | CADX | Option Ex | 12,500 | .00 | 0 |
| 2011-07-11 | CADX | Sale | 3,000 | 8.99 | 26,970 |
| 2011-07-11 | CADX | Option Ex | 3,000 | 3.20 | 9,600 |
| 2011-05-02 | CADX | Sale | 12,000 | 8.35 | 100,164 |
| 2011-05-02 | CADX | Option Ex | 12,000 | 3.20 | 38,400 |
| 2011-04-01 | CADX | Option Ex | 7,000 | 3.20 | 22,400 |
| 2011-04-01 | CADX | Sale | 7,000 | 9.20 | 64,399 |
| 2011-03-04 | CADX | Option Ex | 7,000 | 3.20 | 22,400 |
| 2011-03-04 | CADX | Sale | 7,000 | 8.50 | 59,500 |
| 2011-02-03 | CADX | Option Ex | 39,000 | 3.20 | 124,800 |
| 2011-02-03 | CADX | Sale | 39,000 | 7.38 | 288,015 |
| 2010-11-01 | CADX | Option Ex | 7,000 | 3.20 | 22,400 |
| 2010-11-02 | CADX | Option Ex | 18,000 | 3.20 | 57,600 |
| 2010-11-01 | CADX | Sale | 7,000 | 9.00 | 63,000 |
| 2010-11-02 | CADX | Sale | 18,000 | 9.05 | 162,864 |
| 2010-10-05 | CADX | Option Ex | 7,000 | 3.20 | 22,400 |
| 2010-10-05 | CADX | Sale | 7,000 | 8.50 | 59,500 |
| 2010-09-29 | CADX | Sale | 4,637 | 8.50 | 39,414 |
| 2010-09-29 | CADX | Option Ex | 4,637 | 3.20 | 14,838 |
| 2010-09-27 | CADX | Sale | 2,363 | 8.50 | 20,085 |
| 2010-09-27 | CADX | Option Ex | 2,363 | 3.20 | 7,561 |
| 2010-04-19 | CADX | Option Ex | 1,000 | 3.20 | 3,200 |
| 2010-04-19 | CADX | Sale | 1,000 | 10.00 | 10,000 |
| 2010-02-01 | CADX | Option Ex | 1,000 | 3.20 | 3,200 |
| 2010-02-01 | CADX | Sale | 1,000 | 10.00 | 10,000 |
| 2010-01-05 | CADX | Sale | 1,000 | 10.00 | 10,000 |
| 2010-01-05 | CADX | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-12-17 | CADX | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-12-17 | CADX | Sale | 1,000 | 10.00 | 10,000 |
| 2009-11-05 | CADX | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-11-05 | CADX | Sale | 1,000 | 10.00 | 10,000 |
| 2009-10-01 | CADX | Sale | 1,000 | 10.96 | 10,960 |
| 2009-10-01 | CADX | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-09-01 | CADX | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-09-01 | CADX | Sale | 1,000 | 10.81 | 10,810 |
| 2009-08-03 | CADX | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-08-03 | CADX | Sale | 1,000 | 12.11 | 12,110 |
Table 3. Insider trading of Zogenix, Inc. (ZGNX) by Breitmeyer James B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-12-16 | ZGNX | Option Ex | 5,000 | 8.99 | 44,950 |
| 2019-12-16 | ZGNX | Sale | 5,000 | 50.00 | 250,000 |
| 2019-11-25 | ZGNX | Option Ex | 5,000 | 8.99 | 44,950 |
| 2019-11-25 | ZGNX | Sale | 5,000 | 50.00 | 250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Breitmeyer James B
(Chief Executive Officer of Oncternal Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.